PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
15-Feb-2022 Topas Therapeutics Appoints Cristina de Min, M.D. as Chief Medical Officer Topas Therapeutics GmbH
15-Feb-2022 Heidelberg Pharma Announces First Patient Dosed with Antibody Targeted Amanitin Conjugate HDP-101 in Multiple Myeloma Heidelberg Pharma AG
15-Feb-2022 Cosmo Pharmaceuticals Announces 2021 preliminary results beating guidance, return to dividend distribution AND 2022 guidance Cosmo Pharmaceuticals N.V.
15-Feb-2022 Straumann Group reports revenue exceeding CHF 2 billion Straumann Holding AG
14-Feb-2022 Original-Research: Defence Therapeutics Inc. (von GBC AG) Defence Therapeutics Inc.
11-Feb-2022 Cheplapharm AG: CHEPLAPHARM GMBH ANNOUNCES SUCCESSFUL PRICING OF TERM LOAN B Cheplapharm AG
11-Feb-2022 THEA LAUNCH BLEPHA EYEBAG® FOR RAPID & EFFECTIVE RELIEF OF COMMON EYE CONDITIONS THEA
11-Feb-2022 Medios AG: Bryan, Garnier & Co initiates coverage of Medios with 'Buy' recommendation and price target of €65.00 Medios AG
11-Feb-2022 ProBioGen Signs a Commercial License Agreement with AstraZeneca Providing their GlymaxX® Technology ProBioGen
11-Feb-2022 Coulter Partners strengthens global team with 13 entry level appointments and announces unprecedented group sales growth Coulter Partners
11-Feb-2022 ProBioGen Signs a Commercial License Agreement with AstraZeneca Providing their GlymaxX® Technology B3C newswire
11-Feb-2022 Xlife Sciences AG: Xlife Sciences' shares begin trading on SIX Swiss Exchange Xlife Sciences AG
10-Feb-2022 Release of results for the first quarter 2021/22 (ending 31 December 2021) on 17 February 2022 Douglas GmbH
10-Feb-2022 Aptar Mumbai Celebrates 10 Year Anniversary and Announces Construction of New Facility Aptar Pharma
10-Feb-2022 BioGenes and Alphalyse Collaborate to Optimize ELISA Reagent Characterization for Biomanufacturing BioGenes and Alphalyse
10-Feb-2022 iTeos to Participate in Upcoming Investor Conferences in February iTeos Therapeutics, Inc.
10-Feb-2022 Douglas GmbH: Release of results for the first quarter 2021/22 (ending 31 December 2021) on 17 February 2022 Douglas GmbH
10-Feb-2022 BioGenes and Alphalyse Collaborate to Optimize ELISA Reagent Characterization for Biomanufacturing B3C newswire
10-Feb-2022 CureVac Doses First Participant in Phase 1 Study with Multivalent Influenza Vaccine Candidate Based on Second-Generation mRNA Backbone Developed in Collaboration with GSK CureVac
10-Feb-2022 MICA Biosystems to collaborate with the Cell and Gene Therapy Catapult Cell and Gene Therapy Catapult (CGT Catapult),